Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Campbell

 

Group Leader
Professor Lesley Campbell AM

 

People at high risk for the development of type 2 diabetes (i.e. normal glucose tolerant, healthy, first degree relatives of patients with type 2 diabetes) exhibit features of insulin resistance, whereas subjects without any family history of diabetes do not. Type 2 diabetes is a complex disease that is polygenic and subject to multiple environmental influences. By studying a carefully characterised population well before diabetes develops, it may be possible to unravel the complex array of factors that contribute to the condition.


Much of our work makes use of tissue biopsies to study the early changes in fat cells and in muscle that precede type 2 diabetes.

Staff


dorit_samocha-bonet90.jpgResearch Officer
Dr Dorit Samocha Bonet
Leonie HeilbronnResearch Officer
Dr Leonie Heilbronn
Alex ViardotClinical Research Officer
Dr Alex Viardot
Research Officer
Dr Haiyan Li (Jane)
lynne_schofield90.jpgClinical Research Nurse
Lynne Schofield

Visiting Research Fellow
Dr Lisa Sze



See also:

Chisholm Research Group

Samaras Research Group

News

 

Low levels of PYY hormone a very early indicator of Type 2 diabetes

MEDIA RELEASE: 10 Mar 2008
Garvan scientists have published findings showing that low levels of the hormone PYY could be used as a predictor for the development of Type 2 diabetes. Clinical studies have shown that people with a family history of Type 2 diabetes, but not yet showing signs of insulin resistance themselves, produce lower levels of PYY after eating, a very early sign of pre-diabetes.
 
 

Personal tools